In this environment, breast cancer cells can interact with mesenchymal stem cells (MSCs), leading to an increased production of Th2 cytokines, recruitment of Tregs, and secretion of MSC-mediated TGF-β1 [71]. This evidence concerns the gene TGFB1 and breast carcinoma.